ISSN 2398-2950      

Silybin

ffelis

Synonym(s): Silibin, silybinin, silibinin


Introduction

Name

  • Silybin.

Class of drug

  • Nutraceutical.
  • Nutritional supplement.
  • An active constituent of the extract silymarin from the milk thistle plantSilybum marianum.
  • A flavonolignan.

Description

Chemical name

  • Silybin A+B.

Molecular formula

  • C25H22O10.

Molecular weight

  • 482.44 g/mol.

Physical properties

  • A crystalline solid.

Storage requirements

  • Store in a cool, dry place.

Uses

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Indications

  • Management of hepatic and hepatobiliary disease.
  • Treatment of certain hepatotoxins:
  • Support of brain health including management of cognitive dysfunction   Feline cognitive dysfunction syndrome  .

Administration

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Pharmacokinetics

Precautions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Interactions

with other drugs

  • None reported.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMed Resource.
  • Au A Y, Hasenwinkel J M, & Frondoza C G (2011) Silybin inhibits interleukin-1ß-induced production of pro-inflammatory mediators in canine hepatocyte cultures. J Vet Pharmacol Ther 34(2), 120-129 PubMed.
  • Al-Anati L, Essid E, Reinehr R, & Petzinger E (2009) Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Mol Nut Food Res 53(4), 460-466.
  • Webb C B, McCord K W, & Twedt D C (2009) Assessment of oxidative stress in leukocytes and granulocyte function following oral administration of a silibinin-phosphatidylcholine complex in cats. Am J Vet Res 70, 57-62.
  • Crocenzi F A & Roma M G (2006) Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication. Curr Med Chem 13(9), 1055-1074.
  • Crocenzi F A, Sánchez Pozzi E J, Pelligrino J M, Rodríguez Garay E A, Mottino A D, & Roma M G (2003) Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat. Biochem Pharmacol 66(2), 355-364.
  • Crocenzi F A, Pelligrino J M, Sánchez Pozzi E J, Mottino A D, Rodríguez Garay E A, & Roma M G (2000) Effect of silymarin on biliary bile salt secretion in the rat. Biochem Pharmacol 59(8), 1015-1022.
  • Dehmlow C, Erhard J, & de Groot H (1996) Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin. Hepatology 23(4), 749-754.
  • Dehmlow C, Murawski N, & de Groot (1996) Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 58(18), 1591-1600.
  • Filburn C R, Kettenacker R, & Griffin D W (2007) Bioavailability of a silybin-phosphatidylcholine complex in dogs. J Vet Pharmacol Ther 30(2), 132-138 PubMed.
  • Webb C B, Gustafson D L, & Twedt D C (2012) Bioavailability following oral administration of a silybinin-phosphatidylcholine complex in cats. Intern J Appl Res Vet Med 20(2), 107-112.
  • Vogel G, Tuchweber B, Trost W, & Mengs U (1984) Protection by silibinin against Amanita phalloides intoxication in beagles .Toxicol App Pharmacol 73(3), 355-362.
MEMBER BENEFIT

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!